Latest Pharmaceutical, BioTechnology, Clinical Trials and Biosimilars Industry News

Apex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical Trial

Apex Labs Ltd. (APEX or the Company), a pharmaceutical company optimizing the standard of mental health care with psilocybin, is pleased to its approval by Health Canada to begin APEX-002-A01-03.

SCHOTT Continues Gains in U.S. Market, Invests for Future Organic Growth

SCHOTT, the international technology group and inventor of specialty glass, maintained strong growth in the United States amid global challenges in fiscal year 2021-22.

Mobius Therapeutics™ Granted New US Patent for Injected Ophthalmic Mitomycin-C

Mobius Therapeutics™, LLC, a St. Louis-based perioperative ophthalmic pharmaceutical company, has been issued US Patent Injection Apparatus and Method of Use.